Jerusalem Pharmaceuticals Co. announced unaudited consolidated preliminary financial results for year ended December 31, 2013. For the period, the company's net profit after taxes reached $2,162,958, compared with a net profit after taxes of $195,590 in the audited data for 2012, a net increase of 1,005.9%.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.8 USD | 0.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 68.4M | |
+28.67% | 46.19B | |
+18.57% | 22.88B | |
+20.11% | 14.18B | |
+0.55% | 12.63B | |
+46.16% | 12.07B | |
-1.55% | 7.85B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.80% | 5.14B |
- Stock
- Equities
- Stock Jerusalem Pharmaceuticals Co. Ltd. - Palestine Exchange
- News Jerusalem Pharmaceuticals Co. Ltd.
- Jerusalem Pharmaceuticals Co. Announces Unaudited Consolidated Preliminary Financial Results for Year Ended December 31, 2013